Eighteen of the 23 patients (78%) included in this analysis had clear visual evidence of lesions suspicious for prostate cancer on one or more [89Zr]Zr-PSMA-617 PET/CT scans, while 5 (22%) had no such findings (Table 2). Here, FOLH1 is linked to prostate cancer.